1. Home
  2. SNTG vs EVOK Comparison

SNTG vs EVOK Comparison

Compare SNTG & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTG
  • EVOK
  • Stock Information
  • Founded
  • SNTG 2009
  • EVOK 2007
  • Country
  • SNTG China
  • EVOK United States
  • Employees
  • SNTG N/A
  • EVOK N/A
  • Industry
  • SNTG Finance: Consumer Services
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNTG Finance
  • EVOK Health Care
  • Exchange
  • SNTG Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • SNTG 5.2M
  • EVOK 4.2M
  • IPO Year
  • SNTG 2021
  • EVOK 2013
  • Fundamental
  • Price
  • SNTG $1.75
  • EVOK $2.45
  • Analyst Decision
  • SNTG
  • EVOK
  • Analyst Count
  • SNTG 0
  • EVOK 0
  • Target Price
  • SNTG N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • SNTG 12.2K
  • EVOK 27.3K
  • Earning Date
  • SNTG 04-25-2025
  • EVOK 03-13-2025
  • Dividend Yield
  • SNTG N/A
  • EVOK N/A
  • EPS Growth
  • SNTG N/A
  • EVOK N/A
  • EPS
  • SNTG N/A
  • EVOK N/A
  • Revenue
  • SNTG $146,472.00
  • EVOK $10,249,415.00
  • Revenue This Year
  • SNTG N/A
  • EVOK $99.03
  • Revenue Next Year
  • SNTG N/A
  • EVOK $60.15
  • P/E Ratio
  • SNTG N/A
  • EVOK N/A
  • Revenue Growth
  • SNTG N/A
  • EVOK 97.84
  • 52 Week Low
  • SNTG $1.65
  • EVOK $2.40
  • 52 Week High
  • SNTG $3.97
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • SNTG 42.69
  • EVOK 26.36
  • Support Level
  • SNTG $1.77
  • EVOK $2.51
  • Resistance Level
  • SNTG $1.85
  • EVOK $2.81
  • Average True Range (ATR)
  • SNTG 0.06
  • EVOK 0.29
  • MACD
  • SNTG -0.01
  • EVOK -0.02
  • Stochastic Oscillator
  • SNTG 2.14
  • EVOK 8.12

About SNTG Sentage Holdings Inc.

Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: